published meta-analysis   sensitivity analysis   studies

control in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical improvementdetailed resultsTang, 2020 1.01 [0.59; 1.74] 1.01[0.59; 1.74]Tang, 202010%119NAnot evaluable clinical improvement (time to event analysis only)detailed resultsTang, 2020 1.01 [0.59; 1.74] 1.01[0.59; 1.74]Tang, 202010%119NAnot evaluable viral clearance detailed resultsTang, 2020 0.85 [0.58; 1.23] 0.85[0.58; 1.23]Tang, 202010%150NAnot evaluable viral clearance (time to event analysis only)detailed resultsTang, 2020 0.85 [0.58; 1.23] 0.85[0.58; 1.23]Tang, 202010%150NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-06-17 03:14 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 649,650,589,651,968 - roots T: 290